- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
250
9 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
250 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$193.42 | -0.2% | 59.2% | US$60.6b | US$195.00 | PE90.3x | E38.4% | 1.9% | Diversified Financials | ||
ONON | US$63.04 | 7.7% | 137.3% | US$19.9b | US$62.47 | PE145.3x | E29.7% | n/a | Consumer Durables | ||
NVDA | US$123.70 | -16.0% | 96.3% | US$3.0t | US$173.78 | PE48x | E24.5% | 0.03% | Semiconductors | ||
ALNY | US$273.99 | 2.8% | 58.5% | US$36.0b | US$299.74 | PS16.9x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
MRVL | US$106.79 | -14.7% | 57.7% | US$89.9b | US$127.52 | PS17.2x | E69.5% | 0.2% | Semiconductors | ||
NU | US$12.55 | 4.7% | 45.8% | US$60.8b | US$15.06 | PB7.9x | E25.2% | n/a | Banks | ||
KSPI | US$96.78 | 2.1% | 5.8% | US$18.6b | US$128.18 | PE9.8x | E20.8% | 6.8% | Diversified Financials | ||
ITCI | US$127.02 | -0.1% | 88.6% | US$13.5b | US$127.45 | PS22x | E52.2% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$27.80 | -17.9% | -47.5% | US$16.5b | US$40.79 | PE13.5x | E24.3% | n/a | Tech | ||
DASH | US$185.78 | 4.6% | 78.3% | US$76.6b | US$185.88 | PS7.6x | E44.0% | n/a | Consumer Services | ||
RYAN | US$65.89 | 0.4% | 52.1% | US$17.1b | US$73.98 | PE81.1x | E43.9% | 0.7% | Insurance | ||
VRT | US$110.46 | -25.7% | 96.1% | US$40.0b | US$143.31 | PE71.3x | E26.8% | 0.1% | Capital Goods | ||
EXE | US$102.57 | -4.2% | 33.0% | US$23.6b | US$117.39 | PE93.3x | E64.0% | 2.2% | Energy | ||
XPEV | US$14.81 | 1.9% | 77.8% | US$14.3b | US$14.77 | PS2.7x | E56.7% | n/a | Automobiles | ||
TER | US$122.05 | -9.5% | 26.4% | US$19.9b | US$142.66 | PE38.7x | E22.0% | 0.4% | Semiconductors | ||
SRPT | US$115.45 | -0.6% | -3.0% | US$11.2b | US$184.31 | PE90.5x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
CVNA | US$245.46 | 4.9% | 470.0% | US$51.7b | US$250.91 | PE1855.5x | E37.2% | n/a | Retail | ||
CTRA | US$28.24 | -3.2% | 13.5% | US$20.6b | US$34.59 | PE16.8x | E25.2% | 3.0% | Energy | ||
ZS | US$201.63 | 4.5% | -14.4% | US$31.4b | US$226.04 | PS13.5x | E39.7% | n/a | Software | ||
SN | US$111.78 | 0.1% | 139.3% | US$15.7b | US$122.87 | PE43.6x | E22.4% | n/a | Consumer Durables | ||
NTNX | US$67.76 | 2.0% | 20.6% | US$18.3b | US$81.89 | PS8.1x | E92.0% | n/a | Software | ||
SPOT | US$538.83 | 9.2% | 150.2% | US$107.3b | US$491.34 | PE149.2x | E29.9% | n/a | Media | ||
TEAM | US$271.33 | 4.0% | 8.6% | US$71.5b | US$290.55 | PS15.5x | E59.4% | n/a | Software | ||
WIX | US$242.14 | 3.0% | 90.8% | US$13.8b | US$238.93 | PE145.3x | E32.1% | n/a | Software |